Risk Factors for Community- and Workplace Transmission of COVID-19
- Conditions
- Coronavirus
- Interventions
- Behavioral: Observation of behavior and COVID-19 infection will be conducted.
- Registration Number
- NCT04320732
- Lead Sponsor
- Oslo University Hospital
- Brief Summary
The project is an epidemiological observational study based on an electronic questionnaire on risk factors for COVID-19 in the community and healthcare setting.
- Detailed Description
Summary The data collected will identify real-life risk factors for getting the COVID-19 diagnosis.
The Oslo University Hospital/University of Oslo web-based solution "nettskjema" will be used to collect data and consent forms.
The impact of knowing the risk factors for COVID-19 is tremendous because it can enable governments to conduct more targeted public health measurements than today to reduce the spread of the virus.
Detailed description Research into an ongoing COVID-19 outbreak is difficult because patients are isolated, and supplies of personal protective equipment (PPE) supplies are limited. The risk of transmission to study personal is non-negligible even when PPE is available.
A study design based on an electronic questionnaire and consent from delivered from the Oslo University Hospital/University of Oslo, GDPR (General Data Protection Regulation) compliant "TSD" service has therefore been chosen.
The study will be a case-control study based on a combined electronic consent form and questionnaire that the participants will fill in using a smartphone and electronic identification.
The groups that will be included are:
* Hospitalized and non-hospitalized patients/persons with COVID-19 at all stages of the disease and after the disease
* Hospitalized patients without COVID-19
* Healthcare personal or other groups with an increased risk of COVID-19
* Healthy volunteers
Participants may be followed with repeated questionnaires prospectively.
Biological samples Biological samples may hold crucial information about the susceptibility to COVID-19 and for susceptibility to the progression of the disease. It is within the scope of the study to analyze such samples from a limited number of participants which will be asked to provide such samples or hospitalized patients that have surplus material. The material will be analyzed with non-genetic methods most suitable to provide such information.
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 250000
- Norwegian adult
- Unable to consent
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Individuals tested for COVID-19 infection with negative test Observation of behavior and COVID-19 infection will be conducted. Confirmed by routine laboratory diagnosis Risk groups for COVID-19 exposure Observation of behavior and COVID-19 infection will be conducted. Including, but not limited to healthcare workers. Patients admitted to hospital Observation of behavior and COVID-19 infection will be conducted. Without COVID-19 infection. Individuals with COVID-19 infection Observation of behavior and COVID-19 infection will be conducted. Confirmed by routine laboratory diagnosis. All types of COVID-19 disease from asymptomatic carriers to hospitalized patients can be included. Only subjects \>18 years old will be included in the study. Healthy individuals Observation of behavior and COVID-19 infection will be conducted. Recruitet from the general population
- Primary Outcome Measures
Name Time Method Rate of COVID-19 infection 1 year Diagnosed with serology or direct viral detection
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Oslo University Hospital
🇳🇴Oslo, Norway